Sumitomo Dainippon Pharma Oncology is a global developer of novel cancer therapeutics. Learn about our diverse and purposeful pipeline of targeted therapies.
Location: United States, Massachusetts, Norwood
Employees: 51-200
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Mitsui Glo... | mitsui-glo... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 04.03.2024 | Beta Catenin Market Key Players, Demand and Growth Trends by... | Beta Catenin Market growth BURLINGAME, CALIFORNIA, UNITED STATES, March 4, 2024 /EINPresswire.com/ -... | einpresswi... |
| 03.12.2019 | AbbVie picks first Alzheimer's, Parkinson's targets in M... | → Back in 2018, AbbVie teamed up with protein degradation experts at Mission Therapeutics ... | endpts.com... |
| 20.07.2016 | DNA pioneer James Watson: The cancer moonshot is ‘crap’ but ... | James Watson, whose 1953 discovery of the structure of DNA with Francis Crick launched the revolutio... | statnews.c... |
| 28.12.2012 | The 10 biggest VC-backed acquisitions of 2012 | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |